Simulations Plus
GastroPlus™ ADMET Predictor™ MedChem Studio™ DDDPlus™ MedChem Designer™ ADMET Design Suite™ Membrane Plus™

Latest Publications

Physiologically Based Absorption Modeling to Impact Biopharmaceutics and Formulation Strategies in Drug Development—Industry Case Studies.
Read More

Development of a Unified Dissolution and Precipitation Model and Its Use for the Prediction of Oral Drug Absorption.
Read More

Disease specific modeling: simulation of the pharmacokinetics of meloxicam and ibuprofen in disease state vs. healthy conditions.
Read More

Events

February 29 - American Society for Cellular and Computational Toxicology (ASCCT) Webinar: Integrating In Silico Predictions with Physiologically Based Pharmacokinetic (PBPK) Modeling.
Read More

March 3 - GastroPlus™ User Group Webinar: Development of a Unified Dissolution and Precipitation Model and Its Use for the Prediction of Oral Drug Absorption.
Read More

News

Simulations Plus to Present at Source Capital Group's 2016 Disruptive Growth & Healthcare Conference
Simulations Plus, Inc. (NASDAQ:SLP), a leading provider of simulation and modeling software for pharmaceutical discovery and development, announced to...
Read More

Simulations Plus Announces Quarterly Cash Dividend of $0.05 Per Share
LANCASTER, Calif.--(BUSINESS WIRE)-- Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of simulation and modeling software for pharmaceutical d...
Read More